List of bibliographic references
Number of relevant bibliographic references: 7.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Humans |
| 2 | Chronic |
| 2 | Rheumatology |
| 2 | Treatment |
| 1 | Antibodies, Monoclonal (adverse effects) |
| 1 | Antibodies, Monoclonal (therapeutic use) |
| 1 | Antibodies, Monoclonal, Humanized |
| 1 | Antibodies, Monoclonal, Humanized (therapeutic use) |
| 1 | Antiviral Agents (therapeutic use) |
| 1 | Arteritis |
| 1 | Arthritis, Rheumatoid (drug therapy) |
| 1 | Biological Products (adverse effects) |
| 1 | Biological Products (therapeutic use) |
| 1 | Biological Therapy |
| 1 | Biotherapy |
| 1 | Contraindications |
| 1 | DNA |
| 1 | Evidence-Based Medicine |
| 1 | Female |
| 1 | Follow-Up Studies |
| 1 | Giant Cell Arteritis (diagnosis) |
| 1 | Giant Cell Arteritis (drug therapy) |
| 1 | Giant Cell Arteritis (immunology) |
| 1 | Giant cell |
| 1 | Giant cell arteritis |
| 1 | Glucocorticoids (therapeutic use) |
| 1 | Hepatitis B Vaccines (therapeutic use) |
| 1 | Hepatitis B, Chronic (immunology) |
| 1 | Hepatitis B, Chronic (physiopathology) |
| 1 | Hepatitis B, Chronic (prevention & control) |
| 1 | Hepatitis B, Chronic (therapy) |
| 1 | Herpes Zoster (immunology) |
| 1 | Herpes Zoster (prevention & control) |
| 1 | Herpes Zoster Vaccine (administration & dosage) |
| 1 | Immunization (methods) |
| 1 | Immunomodulation |
| 1 | Immunomodulator |
| 1 | Immunosuppressive Agents (therapeutic use) |
| 1 | Immunosuppressive agent |
| 1 | Interleukin 6 |
| 1 | Interleukin-6 (antagonists & inhibitors) |
| 1 | Interleukin-6 (immunology) |
| 1 | Male |
| 1 | Patient Education as Topic |
| 1 | Polymyalgia rheumatica |
| 1 | Reactivation |
| 1 | Rheumatic Diseases (drug therapy) |
| 1 | Rheumatic Diseases (immunology) |
| 1 | Rheumatoid arthritis |
| 1 | Risk |
| 1 | Risk Assessment |
| 1 | Risk Factors |
| 1 | Safety Management |
| 1 | Spondylarthritis |
| 1 | Systemic disease |
| 1 | Tocilizumab |
| 1 | Treatment Outcome |
| 1 | Tumor Necrosis Factor-alpha (immunology) |
| 1 | Vaccination |
| 1 | Vasculitis |
| 1 | Viral hepatitis B |
| 1 | Virus Activation (immunology) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Charles Masson"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Charles Masson" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Charles Masson
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
